Clinical Trial Update: US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study [Phase 2]

View source ↗

Summary

Clinical trial update indicating that the Phase 2 biologic lung volume reduction therapy for emphysema/COPD sponsored by Aeris Therapeutics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Emphysema

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED